Cost-Effectiveness of Nexplanon® (Etonogestrel Implant) Compared to other Reimbursed Contraceptive Methods in France Based on Real Life Data
Lafuma, A.; Agostini, A.; Linet, T.; Robert, J.; Levy-Bachelot, L.; Godard, C.
Value in Health 18(7): A735-A736
2015
ISSN/ISBN: 1098-3015 PMID: 26534117 DOI: 10.1016/j.jval.2015.09.2818Document Number: 641051
Document emailed within 0-6 h
Related Documents
Linet, T.; Levy Bachelot, L.; Farge, G.; Crespi, S.; Yang, J.; Robert, J.; Fabron, C. 2020: PIH7 Cost-Effectiveness Analysis of Etonogestrel Contraceptive Implant Compared to SIX other Contraceptive Methods Based on Real Life DATA in France Value in Health 23: S539-S540Linet, T.; Levy Bachelot, L.; Farge, G.; Crespi, S.; Yang, J.; Robert, J.; Fabron, C. 2020: PIH7 Cost-Effectiveness Analysis of Etonogestrel Contraceptive Implant Compared to SIX other Contraceptive Methods Based on Real Life DATA in France Value in Health 23: S539-S540
Gariepy, A.M.; Duffy, J.Y.; Xu, X. 2015: Cost-Effectiveness of Immediate Compared with Delayed Postpartum Etonogestrel Implant Insertion Obstetrics and Gynecology 126(1): 47-55
Reed, S.; Do Minh, T.; Lange, J.A.; Koro, C.; Fox, M.; Heinemann, K. 2019: Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA) Contraception 100(1): 31-36
Caruso, S.; Vitale, S.Giovanni.; Fava, V.; Pasqua, S.Di.; Rapisarda, A.Maria.Chiara.; Cianci, S. 2020: Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 25(4): 251-258
Di Carlo, C.; Sansone, A.; De Rosa, N.; Gargano, V.; Tommaselli, G.A.; Nappi, C.; Bifulco, G. 2014: Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(1): 53-56
Mornar, S.; Chan, L.-N.; Mistretta, S.; Neustadt, A.; Martins, S.; Gilliam, M. 2012: Pharmacokinetics of the etonogestrel contraceptive implant in obese women American Journal of Obstetrics and Gynecology 207(2): 110.E1-6
Lartigau-Roussin, C.; Receveur, M.C.; Roussin, J.M.; Bouffart, S.; Abaine, A. 2006: The subcutaneous etonogestrel implant: a new contraceptive method in Mayotte? Bulletin de la Societe de Pathologie Exotique 99(1): 11-14
Maleewong, U.; Kulsomboon, V.; Teerawattananon, Y. 2008: The cost-effectiveness analysis of initiating HIV/AIDS treatment with efavirenz-based regimens compared with nevirapine-based regimens in Thailand Journal of the Medical Association of Thailand 91(Suppl 2): S126-S138
Morrell, K.M.; Cremers, S.; Westhoff, C.L.; Davis, A.R. 2016: Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year Contraception 93(3): 263-265
Biskamp, C.; Kauffman, R.P. 2016: Arm flexion during ultrasound assists localization of an intramuscular etonogestrel contraceptive implant Contraception 93(3): 273-275
Bryant, A.G.; Bauer, A.E.; Stuart, G.S.; Levi, E.E.; Zerden, M.L.; Danvers, A.; Garrett, J.M. 2017: Etonogestrel-Releasing Contraceptive Implant for Postpartum Adolescents: a Randomized Controlled Trial Journal of Pediatric and Adolescent Gynecology 30(3): 389-394
Sonalkar, S.; Hou, M.Y.; Hou, M.; Borgatta, L. 2013: Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study Contraception 88(5): 671-673
Leticee, N.; Viard, J.-P.; Yamgnane, A.; Karmochkine, M.; Benachi, A. 2012: Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz Contraception 85(4): 425-427
Nakhaee, N.; Mirahmadizadeh, A.R.; Gorji, H.A.; Mohammadi, M. 2002: Assessing the cost-effectiveness of contraceptive methods in Shiraz, Islamic Republic of Iran Eastern Mediterranean Health Journal 8(1): 55-63
Modesto, W.; Dal Ava, N.ál.; Monteiro, I.; Bahamondes, L. 2015: Body composition and bone mineral density in users of the etonogestrel-releasing contraceptive implant Archives of Gynecology and Obstetrics 292(6): 1387-1391
Lazorwitz, A.; Aquilante, C.L.; Oreschak, K.; Sheeder, J.; Guiahi, M.; Teal, S. 2019: Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users Obstetrics and Gynecology 133(4): 783-794
Wang, H; Aas, E; Smith, A; Roman, E; Crouch, S; Burton, C; Patmore, R 2017: An Economic Evaluation Model for Follicular Lymphoma (FL): Predicting Treatment Cost, Life Expectancy and Quality-Adjusted Life Year of Different Scenarios Using UK Population Based Observational Data Value in Health 20(9): A425-A426
Mourão, A.F.; Ribeiro, C.él.; Borges, J.; Gonçalves, M.J.ão.; Bernardes, M.; Fernandes, S.; Dezerto, R.; Laires, P.; Machado, P.íc.; Eusébio, M.ón.; Santos, M.J.é; Canhão, H. 2017: Real-life effectiveness of Golimumab in biologic-naïve patients with rheumatoid arthritis - data from the Rheumatic Diseases Portuguese Register (Reuma.pt) Acta Reumatologica Portuguesa 42(Apr-Jun): 141-149
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14